Browsing Topic

ASX biotech stocks

2 posts

Cleo Diagnostics reports its ovarian cancer blood tests superior to ultrasound

Nine moths after listing on the ASX, Cleo Diagnostics (ASX:COV) has made its first major biotech breakthrough.
  • 2 mins
  • 29 May 2024 10:36 (AEST)

Recce Pharma heading closer to full efficacy data for flagship R327

Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial…
  • 1 min
  • 15 May 2024 12:20 (AEST)